Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in the tumor's genome.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Precision Cancer Diagnostic Tests industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests
Market Segment by Product Application
Hospital
Clinic
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Abbott Laboratories
Canon Medical Systems Corporation
Bio-Rad Laboratories
Agilent Technologies
bioMerieux SA
Becton Dickinson and Company
Danaher Corporation
Biocept
Biocartis N.V.
Cynvenio Biosystems
Genomic Health
Menarini Silicon Biosystems SpA
Epigenomics AG
NanoString Technologies
Hologic
General Electric Company
Exosome Diagnostics
Myriad Genetics
Illumina
Foundation Medicine
Thermo Fisher Scientific
Ortho Clinical Diagnostics
Siemens AG
Royal Philips N.V.
Roche Holding AG
QIAGEN N.V.
Vela Diagnostics
Randox Laboratories Ltd.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Precision Cancer Diagnostic Tests consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Precision Cancer Diagnostic Tests market by identifying its various subsegments.
3.Focuses on the key global Precision Cancer Diagnostic Tests manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Precision Cancer Diagnostic Tests with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Precision Cancer Diagnostic Tests submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Precision Cancer Diagnostic Tests Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Precision Cancer Diagnostic Tests Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Precision Cancer Diagnostic Tests Segment by Type
2.1.1 Imaging
2.1.2 Molecular
2.1.3 Histology/Cytology
2.1.4 Tumor Marker Immunoassays
2.1.5 POC Colon Cancer Tests
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Other
2.3 Global Precision Cancer Diagnostic Tests Market Comparison by Regions (2017-2027)
2.3.1 Global Precision Cancer Diagnostic Tests Market Size (2017-2027)
2.3.2 North America Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.3 Europe Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.4 Asia-pacific Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.5 South America Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Precision Cancer Diagnostic Tests Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Precision Cancer Diagnostic Tests Industry Impact
2.5.1 Precision Cancer Diagnostic Tests Business Impact Assessment - Covid-19
2.5.2 Market Trends and Precision Cancer Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Precision Cancer Diagnostic Tests Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Precision Cancer Diagnostic Tests Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Precision Cancer Diagnostic Tests Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Precision Cancer Diagnostic Tests Manufacturer Market Share
3.5 Top 10 Precision Cancer Diagnostic Tests Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Precision Cancer Diagnostic Tests Market
3.7 Key Manufacturers Precision Cancer Diagnostic Tests Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Precision Cancer Diagnostic Tests Industry Key Manufacturers
4.1 Abbott Laboratories
4.1.1 Company Details
4.1.2 Abbott Laboratories Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Abbott Laboratories News
4.2 Canon Medical Systems Corporation
4.2.1 Company Details
4.2.2 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.2.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Canon Medical Systems Corporation News
4.3 Bio-Rad Laboratories
4.3.1 Company Details
4.3.2 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.3.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Bio-Rad Laboratories News
4.4 Agilent Technologies
4.4.1 Company Details
4.4.2 Agilent Technologies Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.4.3 Agilent Technologies Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Agilent Technologies News
4.5 bioMerieux SA
4.5.1 Company Details
4.5.2 bioMerieux SA Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.5.3 bioMerieux SA Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 bioMerieux SA News
4.6 Becton Dickinson and Company
4.6.1 Company Details
4.6.2 Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.6.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Becton Dickinson and Company News
4.7 Danaher Corporation
4.7.1 Company Details
4.7.2 Danaher Corporation Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.7.3 Danaher Corporation Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Danaher Corporation News
4.8 Biocept
4.8.1 Company Details
4.8.2 Biocept Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.8.3 Biocept Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Biocept News
4.9 Biocartis N.V.
4.9.1 Company Details
4.9.2 Biocartis N.V. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.9.3 Biocartis N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Biocartis N.V. News
4.10 Cynvenio Biosystems
4.10.1 Company Details
4.10.2 Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.10.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Cynvenio Biosystems News
4.11 Genomic Health
4.11.1 Company Details
4.11.2 Genomic Health Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.11.3 Genomic Health Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Genomic Health News
4.12 Menarini Silicon Biosystems SpA
4.12.1 Company Details
4.12.2 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.12.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Menarini Silicon Biosystems SpA News
4.13 Epigenomics AG
4.13.1 Company Details
4.13.2 Epigenomics AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.13.3 Epigenomics AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Epigenomics AG News
4.14 NanoString Technologies
4.14.1 Company Details
4.14.2 NanoString Technologies Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.14.3 NanoString Technologies Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 NanoString Technologies News
4.15 Hologic
4.15.1 Company Details
4.15.2 Hologic Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.15.3 Hologic Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Hologic News
4.16 General Electric Company
4.16.1 Company Details
4.16.2 General Electric Company Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.16.3 General Electric Company Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 General Electric Company News
4.17 Exosome Diagnostics
4.17.1 Company Details
4.17.2 Exosome Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.17.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Exosome Diagnostics News
4.18 Myriad Genetics
4.18.1 Company Details
4.18.2 Myriad Genetics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.18.3 Myriad Genetics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 Myriad Genetics News
4.19 Illumina
4.19.1 Company Details
4.19.2 Illumina Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.19.3 Illumina Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.19.4 Main Business Overview
4.19.5 Illumina News
4.20 Foundation Medicine
4.20.1 Company Details
4.20.2 Foundation Medicine Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.20.3 Foundation Medicine Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.20.4 Main Business Overview
4.20.5 Foundation Medicine News
4.21 Thermo Fisher Scientific
4.21.1 Company Details
4.21.2 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.21.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.21.4 Main Business Overview
4.21.5 Thermo Fisher Scientific News
4.22 Ortho Clinical Diagnostics
4.22.1 Company Details
4.22.2 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.22.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.22.4 Main Business Overview
4.22.5 Ortho Clinical Diagnostics News
4.23 Siemens AG
4.23.1 Company Details
4.23.2 Siemens AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.23.3 Siemens AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.23.4 Main Business Overview
4.23.5 Siemens AG News
4.24 Royal Philips N.V.
4.24.1 Company Details
4.24.2 Royal Philips N.V. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.24.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.24.4 Main Business Overview
4.24.5 Royal Philips N.V. News
4.25 Roche Holding AG
4.25.1 Company Details
4.25.2 Roche Holding AG Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.25.3 Roche Holding AG Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.25.4 Main Business Overview
4.25.5 Roche Holding AG News
4.26 QIAGEN N.V.
4.26.1 Company Details
4.26.2 QIAGEN N.V. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.26.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.26.4 Main Business Overview
4.26.5 QIAGEN N.V. News
4.27 Vela Diagnostics
4.27.1 Company Details
4.27.2 Vela Diagnostics Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.27.3 Vela Diagnostics Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.27.4 Main Business Overview
4.27.5 Vela Diagnostics News
4.28 Randox Laboratories Ltd.
4.28.1 Company Details
4.28.2 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Introduction, Application and Specification
4.28.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.28.4 Main Business Overview
4.28.5 Randox Laboratories Ltd. News
5 Global Precision Cancer Diagnostic Tests Sales Categorized by Regions
5.1 Global Precision Cancer Diagnostic Tests Revenue, Sales and Market Share by Regions
5.1.1 Global Precision Cancer Diagnostic Tests Sales and Market Share by Regions (2017-2022)
5.1.2 Global Precision Cancer Diagnostic Tests Revenue and Market Share by Regions (2017-2022)
5.2 North America Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
5.3 Europe Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
5.5 South America Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
6 North America Precision Cancer Diagnostic Tests Market Size Categorized by Countries
6.1 North America Precision Cancer Diagnostic Tests Sales, Revenue and Market Share by Countries
6.1.1 North America Precision Cancer Diagnostic Tests Sales (Volume) by Countries (2017-2022)
6.1.2 North America Precision Cancer Diagnostic Tests Revenue by Countries (2017-2022)
6.1.3 United States Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
6.1.4 Canada Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
6.1.5 Mexico Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
6.2 North America Precision Cancer Diagnostic Tests Revenue (Value) by Manufacturers
6.3 North America Precision Cancer Diagnostic Tests Sales and Market Share by Type (2017-2022)
6.4 North America Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
7 Europe Precision Cancer Diagnostic Tests Market Size Categorized by Countries
7.1 Europe Precision Cancer Diagnostic Tests Sales, Revenue and Market Share by Countries
7.1.1 Europe Precision Cancer Diagnostic Tests Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Precision Cancer Diagnostic Tests Revenue by Countries (2017-2022)
7.1.3 Germany Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.1.4 UK Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.1.5 France Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.1.6 Russia Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.1.7 Italy Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.1.8 Spain Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
7.2 Europe Precision Cancer Diagnostic Tests Revenue (Value) by Manufacturers
7.3 Europe Precision Cancer Diagnostic Tests Sales and Market Share by Type (2017-2022)
7.4 Europe Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
8 Asia-Pacific Precision Cancer Diagnostic Tests Market Size Categorized by Countries
8.1 Asia-pacific Precision Cancer Diagnostic Tests Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Precision Cancer Diagnostic Tests Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Precision Cancer Diagnostic Tests Revenue by Countries (2017-2022)
8.1.3 China Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.1.4 South Korea Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.1.5 Japan Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.1.6 Australia Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.1.7 India Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Precision Cancer Diagnostic Tests Revenue (Value) by Manufacturers
8.3 Asia-pacific Precision Cancer Diagnostic Tests Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
9 South America Precision Cancer Diagnostic Tests Market Size Categorized by Countries
9.1 South America Precision Cancer Diagnostic Tests Sales, Revenue and Market Share by Countries
9.1.1 South America Precision Cancer Diagnostic Tests Sales (Volume) by Countries (2017-2022)
9.1.2 South America Precision Cancer Diagnostic Tests Revenue by Countries (2017-2022)
9.1.3 Brazil Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
9.2 South America Precision Cancer Diagnostic Tests Sales and Market Share by Type (2017-2022)
9.3 South America Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
10 Middle East and Africa Precision Cancer Diagnostic Tests Market Size Categorized by Countries
10.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Precision Cancer Diagnostic Tests Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Precision Cancer Diagnostic Tests Revenue by Countries (2017-2022)
10.1.3 GCC Countries Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
10.1.4 Turkey Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
10.1.5 Egypt Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
10.1.6 South America Precision Cancer Diagnostic Tests Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Precision Cancer Diagnostic Tests Sales and Market Share by Type
10.3 Middle East and Africa Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
11 Global Precision Cancer Diagnostic Tests Market Segment by Type
11.1 Global Precision Cancer Diagnostic Tests Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Precision Cancer Diagnostic Tests Sales and Market Share by Type (2017-2022)
11.1.2 Global Precision Cancer Diagnostic Tests Revenue and Market Share by Type (2017-2022)
11.2 Imaging Sales Growth Rate and Price
11.2.1 Global Imaging Sales Growth Rate (2017-2022)
11.2.2 Global Imaging Price (2017-2022)
11.3 Molecular Sales Growth Rate and Price
11.3.1 Global Molecular Sales Growth Rate (2017-2022)
11.3.2 Global Molecular Price (2017-2022)
11.4 Histology/Cytology Sales Growth Rate and Price
11.4.1 Global Histology/Cytology Sales Growth Rate (2017-2022)
11.4.2 Global Histology/Cytology Price (2017-2022)
11.5.1 Global Tumor Marker Immunoassays Sales Growth Rate (2017-2022)
11.5.2 Global Tumor Marker Immunoassays Price (2017-2022)
11.6 POC Colon Cancer Tests Sales Growth Rate and Price
11.6.1 Global POC Colon Cancer Tests Sales Growth Rate (2017-2022)
11.6.2 Global POC Colon Cancer Tests Price (2017-2022)
12 Global Precision Cancer Diagnostic Tests Market Segment by Application
12.1 Global Precision Cancer Diagnostic Tests Sales Market Share by Application (2017-2022)
12.2 Hospital Sales Growth Rate (2017-2022)
12.3 Clinic Sales Growth Rate (2017-2022)
12.4 Other Sales Growth Rate (2017-2022)
13 Global Precision Cancer Diagnostic Tests Market Forecast
13.1 Global Precision Cancer Diagnostic Tests Revenue, Sales and Growth Rate (2022-2027)
13.2 Precision Cancer Diagnostic Tests Market Forecast by Regions (2022-2027)
13.2.1 North America Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
13.2.2 Europe Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
13.2.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
13.2.4 South America Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
13.2.5 Middle East & Africa Precision Cancer Diagnostic Tests Market Forecast (2022-2027)
13.3 Precision Cancer Diagnostic Tests Market Forecast by Type (2022-2027)
13.3.1 Global Precision Cancer Diagnostic Tests Sales Forecast by Type (2022-2027)
13.3.2 Global Precision Cancer Diagnostic Tests Market Share Forecast by Type (2022-2027)
13.4 Precision Cancer Diagnostic Tests Market Forecast by Application (2022-2027)
13.4.1 Global Precision Cancer Diagnostic Tests Sales Forecast by Application (2022-2027)
13.4.2 Global Precision Cancer Diagnostic Tests Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Precision Cancer Diagnostic Tests Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Precision Cancer Diagnostic Tests Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Precision Cancer Diagnostic Tests
Figure Market Concentration Ratio and Market Maturity Analysis of Precision Cancer Diagnostic Tests
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Precision Cancer Diagnostic Tests Market Size by Type
Figure Global Market Share of Precision Cancer Diagnostic Tests by Type in 2021
Figure Imaging Picture
Figure Molecular Picture
Figure Histology/Cytology Picture
Figure Tumor Marker Immunoassays Picture
Figure POC Colon Cancer Tests Picture
Table Global Precision Cancer Diagnostic Tests Market Size (Volume) by Application
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Precision Cancer Diagnostic Tests Comparison by Regions (M USD) 2017-2027
Figure Global Precision Cancer Diagnostic Tests Market Size (Million US$) (2017-2027)
Figure North America Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Precision Cancer Diagnostic Tests Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Precision Cancer Diagnostic Tests Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Precision Cancer Diagnostic Tests Sales by Manufacturer (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Sales Market Share by Manufacturer in 2021
Table Global Precision Cancer Diagnostic Tests Revenue by Manufacturer (2017-2022)
Figure Global Precision Cancer Diagnostic Tests Revenue Market Share by Manufacturer in 2021
Table Global Precision Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Precision Cancer Diagnostic Tests Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Precision Cancer Diagnostic Tests Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Precision Cancer Diagnostic Tests Market
Table Key Manufacturers Precision Cancer Diagnostic Tests Product Type
Table Mergers & Acquisitions Planning
Table Abbott Laboratories Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Abbott Laboratories
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Abbott Laboratories 2017-2022
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Canon Medical Systems Corporation Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Canon Medical Systems Corporation
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Canon Medical Systems Corporation 2017-2022
Table Canon Medical Systems Corporation Main Business
Table Canon Medical Systems Corporation Recent Development
Table Bio-Rad Laboratories Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Bio-Rad Laboratories
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bio-Rad Laboratories 2017-2022
Table Bio-Rad Laboratories Main Business
Table Bio-Rad Laboratories Recent Development
Table Agilent Technologies Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Agilent Technologies
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Agilent Technologies 2017-2022
Table Agilent Technologies Main Business
Table Agilent Technologies Recent Development
Table bioMerieux SA Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of bioMerieux SA
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of bioMerieux SA 2017-2022
Table bioMerieux SA Main Business
Table bioMerieux SA Recent Development
Table Becton Dickinson and Company Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Becton Dickinson and Company
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Becton Dickinson and Company 2017-2022
Table Becton Dickinson and Company Main Business
Table Becton Dickinson and Company Recent Development
Table Danaher Corporation Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Danaher Corporation
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Danaher Corporation 2017-2022
Table Danaher Corporation Main Business
Table Danaher Corporation Recent Development
Table Biocept Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Biocept
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocept 2017-2022
Table Biocept Main Business
Table Biocept Recent Development
Table Biocartis N.V. Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Biocartis N.V.
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biocartis N.V. 2017-2022
Table Biocartis N.V. Main Business
Table Biocartis N.V. Recent Development
Table Cynvenio Biosystems Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Cynvenio Biosystems
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cynvenio Biosystems 2017-2022
Table Cynvenio Biosystems Main Business
Table Cynvenio Biosystems Recent Development
Table Genomic Health Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Genomic Health
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Genomic Health 2017-2022
Table Genomic Health Main Business
Table Genomic Health Recent Development
Table Menarini Silicon Biosystems SpA Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Menarini Silicon Biosystems SpA
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Menarini Silicon Biosystems SpA 2017-2022
Table Menarini Silicon Biosystems SpA Main Business
Table Menarini Silicon Biosystems SpA Recent Development
Table Epigenomics AG Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Epigenomics AG
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Epigenomics AG 2017-2022
Table Epigenomics AG Main Business
Table Epigenomics AG Recent Development
Table NanoString Technologies Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of NanoString Technologies
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of NanoString Technologies 2017-2022
Table NanoString Technologies Main Business
Table NanoString Technologies Recent Development
Table Hologic Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Hologic
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hologic 2017-2022
Table Hologic Main Business
Table Hologic Recent Development
Table General Electric Company Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of General Electric Company
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of General Electric Company 2017-2022
Table General Electric Company Main Business
Table General Electric Company Recent Development
Table Exosome Diagnostics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Exosome Diagnostics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Exosome Diagnostics 2017-2022
Table Exosome Diagnostics Main Business
Table Exosome Diagnostics Recent Development
Table Myriad Genetics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Myriad Genetics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Myriad Genetics 2017-2022
Table Myriad Genetics Main Business
Table Myriad Genetics Recent Development
Table Illumina Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Illumina
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Illumina 2017-2022
Table Illumina Main Business
Table Illumina Recent Development
Table Foundation Medicine Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Foundation Medicine
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Foundation Medicine 2017-2022
Table Foundation Medicine Main Business
Table Foundation Medicine Recent Development
Table Thermo Fisher Scientific Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Thermo Fisher Scientific
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Thermo Fisher Scientific 2017-2022
Table Thermo Fisher Scientific Main Business
Table Thermo Fisher Scientific Recent Development
Table Ortho Clinical Diagnostics Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Ortho Clinical Diagnostics
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ortho Clinical Diagnostics 2017-2022
Table Ortho Clinical Diagnostics Main Business
Table Ortho Clinical Diagnostics Recent Development
Table Siemens AG Company Profile
Table Precision Cancer Diagnostic Tests Product Introduction, Application and Specification of Siemens AG
Table Precision Cancer Diagnostic Tests Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Siemens AG 2017-2022
Table Siemens AG Main Business
Table Siemens AG Rec
Abbott Laboratories
Canon Medical Systems Corporation
Bio-Rad Laboratories
Agilent Technologies
bioMerieux SA
Becton Dickinson and Company
Danaher Corporation
Biocept
Biocartis N.V.
Cynvenio Biosystems
Genomic Health
Menarini Silicon Biosystems SpA
Epigenomics AG
NanoString Technologies
Hologic
General Electric Company
Exosome Diagnostics
Myriad Genetics
Illumina
Foundation Medicine
Thermo Fisher Scientific
Ortho Clinical Diagnostics
Siemens AG
Royal Philips N.V.
Roche Holding AG
QIAGEN N.V.
Vela Diagnostics
Randox Laboratories Ltd.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)